home page
IPBF: who are we ?
site map
interstitial cystitis &
painful bladder syndrome (IC/PBS)
treatment of IC/PBS
other pelvic pain conditions
overactive bladder syndrome
incontinence
associated disorders
the urinary tract: how it works
news & reviews
literature: new scientific
literature: selected topics
IPBF newsletters
IPBF publications
information in other languages
glossary of terms: A-Z
information for professionals
books, videos, CDs
calendar
how to start and run a support group
surveys
global IC/PBS support groups, contact persons and related organizations
donations & sponsoring
useful links
disclaimer & copyright
selected literature on
neuro-urology
click on the title to jump to the abstract if available
Lower urinary tract disease: what are we trying to treat and in whom?
Heaton JP. Br J Pharmacol 2006;147 Suppl 2:S2-S13
Integrated control of lower urinary tract - clinical perspective.
Fowler CJ. Br J Pharmacol 2006;147 Suppl 2:S14-24
Integrative control of the lower urinary tract: preclinical perspective.
de Groat WC. Br J Pharmacol 2006;147 Suppl 2:S25-40
Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.
Christ GJ, Hodges S. Br J Pharmacol 2006;147 Suppl 2:S41-55
In vitro models: research in physiology and pharmacology of the lower urinary tract.
Moreland RB. Br J Pharmacol 2006;147 Suppl 2:S56-61
Animal models in urological disease and sexual dysfunction.
McMurray G, Casey JH, Naylor AM. Br J Pharmacol 2006;147 Suppl 2:S62-79
Muscarinic receptors in the bladder: from basic research to therapeutics.
Hegde SS. Br J Pharmacol 2006;147 Suppl 2:S80-7
alpha(1)-, alpha(2)- and beta-adrenoceptors in the urinary bladder, urethra and prostate.
Michel MC, Vrydag W. Br J Pharmacol 2006;147 Suppl 2:S88-S119
The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.
Ramage AG. Br J Pharmacol 2006;147 Suppl 2:S120-31
Purinoceptors as therapeutic targets for lower urinary tract dysfunction.
Ford AP, Gever JR, Nunn PA,
et al.
Br J Pharmacol 2006;147 Suppl 2:S132-43
Late-stage clinical development in lower urogenital targets: sexual dysfunction.
Azam U.Br J Pharmacol 2006;147 Suppl 2:S153-9
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.
Mansfield KJ, Liu L, Mitchelson FJ,
et al.
Br J Pharmacol 2005;144:1089-99
Micturition and the soul
.
Holstege G. J Comp Neurol 2005;493:15-20
Neurophysiology of stress urinary incontinence
.
Chancellor
MB, Yoshimura N. Rev Urol 2004;6 Suppl 3:S19-28 (full article available)
Brain control of the lower urinary tract
.
Blok BF. Scand J Urol Nephrol Suppl 2002;(210):11-5
Central pathways controlling micturition and urinary incontinence
.
Blok BF. Urology 2002;59(5 Suppl 1):13-7
Neural control of the urethra
.
De Groat WC, Fraser MO, Yoshiyama M,
et al.
Scand J Urol Nephrol Suppl 2001;(207):35-43; discussion 106-25
The central control of micturition and continence: implications for urology
.
Blok BF, Holstege G. BJU Int 1999 Mar:83 Suppl 2:1-6
The central nervous system control of micturition and cats and humans
.
Blok BF, Holstege G. Behav Brain Res 1998;92:119-25
A neurologic basis for the overactive bladder
.
De Groat WC. Urology 1997;50(6A Auppl):36-52; discussion 53-6.
updated 12.11.2006 14:54
© 2006-2012
International Painful Bladder Foundation (IPBF)
.
All rights reserved.